Document is current
Any future updates will be listed below
-
Authors
Bangen, Katherine J. https://orcid.org/0000-0002-1363-3179
Smirnov, Denis S.
Delano-Wood, Lisa
Wierenga, Christina E.
Bondi, Mark W.
Salmon, David P.
Galasko, Douglas
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (1I01CX001842)
U.S. Department of Veterans Affairs (1I01CX000565)
National Institute on Aging (P30 AG062429)
National Institute on Aging (R01 AG063782)
National Institute on Aging (R01 AG049810)
National Institute on Aging (R01 AG054049)
Alzheimer's Association (AARG-18-566254)
- License Information
-
More Information
Article History
Received: 4 January 2021
Accepted: 31 May 2021
First Online: 1 July 2021
Declarations
:
: All procedures were approved by the Institutional Review Boards at UCSD. Written informed consent was obtained from every research participant according to the Declaration of Helsinki and the Belmont Report.
: Not applicable.
: D. Galasko serves as an editor for Alzheimer’s Research and Therapy; is a consultant for Biogen, Inc., Fujirebio, Inc., and Amprion, Inc.; and serves on a Data Safety Monitoring Board for Cognition Therapeutics. D.P. Salmon serves as a paid consultant for Takeda Pharmaceuticals, Inc.; Aptinyx, Inc.; and Biogen, Inc. M. Bondi receives royalties from Oxford University Press. Other authors declare that they have no competing interests.
